CAT and schizophrenia: In 2017, all the necessary experiments for the first time were performed to prove the assignment of catalase activity directly to antibodies, and showed, using IgGs of healthy donors and patients with schizophrenia, that human polyclonal IgGs possess catalase activity [161].